ELETRIPTAN HYDROBROMIDE

ELETRIPTAN HYDROBROMIDE was reported 7041 times

ELETRIPTAN HYDROBROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PLEURAL RUB 9 0.2727
1 HEPATIC INFILTRATION EOSINOPHILIC 6 0.0984
2 ENZYME INHIBITION 9 0.0938
3 MEDICATION OVERUSE HEADACHE 55 0.0643
4 EYELID MYOCLONUS 4 0.0400
5 BLOOD PROLACTIN DECREASED 6 0.0343
6 STATUS MIGRAINOSUS 5 0.0311
7 HERPES OESOPHAGITIS 4 0.0187
8 SEASONAL AFFECTIVE DISORDER 4 0.0126
9 TYPE V HYPERLIPIDAEMIA 6 0.0123
10 RECALLED PRODUCT ADMINISTERED 115 0.0120
11 RUBBER SENSITIVITY 17 0.0111
12 DEAFNESS TRANSITORY 9 0.0105
13 VASOCONSTRICTION 9 0.0103
14 SPONDYLOARTHROPATHY 6 0.0100
15 CAROTID ARTERY DISSECTION 4 0.0094
16 CUTANEOUS SARCOIDOSIS 4 0.0093
17 MIGRAINE 863 0.0090
18 GALLBLADDER CHOLESTEROLOSIS 4 0.0088
19 INTRACRANIAL VENOUS SINUS THROMBOSIS 9 0.0084
20 ABORTION MISSED 10 0.0079
21 VICTIM OF SEXUAL ABUSE 4 0.0076
22 PRE-EXISTING CONDITION IMPROVED 44 0.0070
23 THALAMIC INFARCTION 4 0.0067
24 ANAEMIA OF CHRONIC DISEASE 6 0.0066
25 AURICULAR SWELLING 4 0.0066
26 CLUSTER HEADACHE 9 0.0066
27 VASOSPASM 6 0.0065
28 BILIARY DYSKINESIA 11 0.0065
29 AURA 12 0.0064
30 INHIBITORY DRUG INTERACTION 10 0.0063
31 CEREBRAL CYST 4 0.0058
32 BORDERLINE PERSONALITY DISORDER 4 0.0056
33 PULMONARY SARCOIDOSIS 6 0.0053
34 HYPERACUSIS 19 0.0051
35 IMMUNOGLOBULINS DECREASED 7 0.0051
36 PRINZMETAL ANGINA 5 0.0050
37 COMMUNICATION DISORDER 19 0.0050
38 BUTTERFLY RASH 5 0.0049
39 OESOPHAGEAL SPASM 9 0.0049
40 COVID-19 IMMUNISATION 4 0.0048
41 RELAPSING-REMITTING MULTIPLE SCLEROSIS 4 0.0046
42 CHOLECYSTITIS CHRONIC 31 0.0046
43 APPLICATION SITE PARAESTHESIA 6 0.0046
44 SENSATION OF PRESSURE 4 0.0045
45 ESSENTIAL HYPERTENSION 8 0.0044
46 MIGRAINE WITH AURA 11 0.0040
47 INFECTIOUS PLEURAL EFFUSION 6 0.0039
48 CONSCIOUSNESS FLUCTUATING 4 0.0038
49 GALLBLADDER INJURY 7 0.0036
50 COMPLEX REGIONAL PAIN SYNDROME 5 0.0034
51 PRODUCT CONTAMINATION MICROBIAL 4 0.0034
52 LIVEDO RETICULARIS 7 0.0033
53 DRUG EFFECT DELAYED 15 0.0033
54 CONCUSSION 25 0.0032
55 FEELINGS OF WORTHLESSNESS 4 0.0031
56 TENSION HEADACHE 13 0.0030
57 MENINGITIS VIRAL 4 0.0029
58 CERVICAL SPINAL STENOSIS 5 0.0029
59 ROTATOR CUFF REPAIR 5 0.0029
60 INFUSION SITE DISCHARGE 5 0.0028
61 CATAPLEXY 4 0.0028
62 TERMINAL INSOMNIA 5 0.0028
63 FEAR OF DISEASE 5 0.0028
64 RENAL INFARCT 4 0.0028
65 OPTIC NEURITIS 25 0.0027
66 HYPOTHALAMO-PITUITARY DISORDER 4 0.0027
67 CLUMSINESS 7 0.0026
68 BACTERIAL VAGINOSIS 4 0.0026
69 POST-TRAUMATIC STRESS DISORDER 17 0.0025
70 BLADDER PAIN 8 0.0025
71 RETINAL TEAR 6 0.0024
72 FIBROMYALGIA 59 0.0024
73 ILLUSION 4 0.0024
74 CEREBELLAR INFARCTION 4 0.0024
75 CRANIOCEREBRAL INJURY 7 0.0023
76 VITREOUS DETACHMENT 5 0.0023
77 ENDOMETRIOSIS 11 0.0023
78 GASTRIC BYPASS 5 0.0023
79 COLONOSCOPY 5 0.0023
80 JUGULAR VEIN THROMBOSIS 4 0.0022
81 OBSESSIVE THOUGHTS 4 0.0022
82 FLAT AFFECT 5 0.0022
83 BREAST PAIN 23 0.0022
84 LYMPH NODE PAIN 4 0.0021
85 MENOPAUSAL SYMPTOMS 5 0.0021
86 BLADDER SPASM 4 0.0021
87 TRISMUS 11 0.0021
88 SNORING 8 0.0021
89 SINUS OPERATION 5 0.0021
90 INTENTIONAL MISUSE 4 0.0021
91 HYPERTONIC BLADDER 6 0.0021
92 NECK INJURY 6 0.0020
93 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
94 MUSCLE TIGHTNESS 33 0.0020
95 BLINDNESS TRANSIENT 15 0.0020
96 THROAT TIGHTNESS 55 0.0020
97 IMPAIRED DRIVING ABILITY 23 0.0020
98 INTRACRANIAL ANEURYSM 8 0.0020
99 TRIGEMINAL NEURALGIA 8 0.0020
100 THROMBOPHLEBITIS SUPERFICIAL 6 0.0020
101 DRUG TOLERANCE 10 0.0020
102 DRUG ABUSER 12 0.0020
103 MENOPAUSE 5 0.0019
104 HYPERPARATHYROIDISM 4 0.0019
105 IMPAIRED WORK ABILITY 40 0.0019
106 THERAPY PARTIAL RESPONDER 29 0.0019
107 VULVOVAGINAL DRYNESS 6 0.0019
108 FACIAL PALSY 4 0.0019
109 ANTINUCLEAR ANTIBODY POSITIVE 6 0.0018
110 RENAL TUBULAR ACIDOSIS 4 0.0018
111 DYSPHEMIA 8 0.0018
112 ACCIDENT AT WORK 4 0.0018
113 MULTIPLE ALLERGIES 14 0.0018
114 SLEEP APNOEA SYNDROME 34 0.0018
115 FEAR OF DEATH 4 0.0018
116 HEREDITARY ANGIOEDEMA 19 0.0018
117 BLOOD THYROID STIMULATING HORMONE DECREASED 8 0.0018
118 PHOTOPHOBIA 33 0.0018
119 FEELING DRUNK 13 0.0017
120 ARTERIOSPASM CORONARY 7 0.0017
121 CERVICAL VERTEBRAL FRACTURE 6 0.0017
122 DRUG EFFECT INCOMPLETE 63 0.0017
123 UTERINE DISORDER 4 0.0017
124 HANGOVER 6 0.0017
125 INGROWING NAIL 4 0.0017
126 GALLBLADDER DISORDER 30 0.0017
127 LACUNAR INFARCTION 4 0.0017
128 COLITIS ISCHAEMIC 11 0.0016
129 NECK PAIN 91 0.0016
130 HYPERPARATHYROIDISM SECONDARY 4 0.0016
131 INFUSION SITE PRURITUS 5 0.0016
132 SEROTONIN SYNDROME 30 0.0016
133 DRUG TITRATION ERROR 4 0.0015
134 SENSATION OF HEAVINESS 6 0.0015
135 PRODUCT PACKAGING DIFFICULT TO OPEN 4 0.0015
136 PERSONALITY DISORDER 4 0.0015
137 AFFECTIVE DISORDER 12 0.0015
138 NEPHROGENIC ANAEMIA 7 0.0015
139 DRUG DISPENSING ERROR 23 0.0015
140 ANGIONEUROTIC OEDEMA 4 0.0015
141 SPINAL DISORDER 14 0.0015
142 HEPATIC CYST 5 0.0015
143 DEMYELINATION 6 0.0015
144 VIITH NERVE PARALYSIS 5 0.0014
145 DRUG SCREEN FALSE POSITIVE 4 0.0014
146 STREPTOCOCCAL INFECTION 8 0.0014
147 APPLICATION SITE BURN 7 0.0014
148 ACTIVITIES OF DAILY LIVING IMPAIRED 28 0.0014
149 SEASONAL ALLERGY 20 0.0014
150 NEONATAL RESPIRATORY DISTRESS SYNDROME 5 0.0014
151 INCORRECT DRUG ADMINISTRATION RATE 6 0.0014
152 IMMUNODEFICIENCY 21 0.0014
153 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
154 BRAIN INJURY 14 0.0014
155 VISUAL DISTURBANCE 8 0.0014
156 LIP PAIN 4 0.0014
157 PHOTOSENSITIVITY REACTION 23 0.0014
158 INCOHERENT 9 0.0014
159 PANIC REACTION 10 0.0014
160 DYSPHORIA 7 0.0014
161 BRADYPHRENIA 9 0.0014
162 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
163 SINUS HEADACHE 8 0.0013
164 ROAD TRAFFIC ACCIDENT 56 0.0013
165 AUTOIMMUNE DISORDER 13 0.0013
166 MATERNAL EXPOSURE TIMING UNSPECIFIED 5 0.0013
167 COELIAC DISEASE 13 0.0013
168 EYE INJURY 4 0.0013
169 THERAPEUTIC PRODUCT EFFECT DELAYED 6 0.0013
170 CROHN'S DISEASE 9 0.0013
171 TONGUE OEDEMA 5 0.0013
172 BLADDER DISORDER 13 0.0013
173 BRAIN DEATH 4 0.0013
174 CHEILITIS 7 0.0013
175 BACK DISORDER 21 0.0013
176 PANIC DISORDER 5 0.0013
177 FEELING OF DESPAIR 6 0.0013
178 TIC 7 0.0013
179 WOUND SECRETION 5 0.0013
180 PRODUCT PACKAGING ISSUE 12 0.0013
181 PRE-ECLAMPSIA 6 0.0013
182 NERVE INJURY 14 0.0013
183 INTERVERTEBRAL DISC PROTRUSION 27 0.0012
184 PHARYNGEAL OEDEMA 19 0.0012
185 HOMICIDAL IDEATION 5 0.0012
186 SPINAL FUSION SURGERY 5 0.0012
187 BODY HEIGHT DECREASED 13 0.0012
188 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
189 EXPIRED DRUG ADMINISTERED 6 0.0012
190 SINUS DISORDER 24 0.0012
191 LYME DISEASE 4 0.0012
192 BIPOLAR DISORDER 13 0.0012
193 PAROSMIA 9 0.0012
194 CHEST DISCOMFORT 122 0.0012
195 VULVOVAGINAL PRURITUS 6 0.0012
196 MUSCLE FATIGUE 5 0.0012
197 SUBARACHNOID HAEMORRHAGE 12 0.0012
198 MOTOR DYSFUNCTION 12 0.0012
199 RETCHING 25 0.0012
200 HEADACHE 733 0.0012
201 HEARING IMPAIRED 7 0.0012
202 CEREBRAL ISCHAEMIA 6 0.0012
203 HORDEOLUM 5 0.0012
204 PARAESTHESIA 181 0.0011
205 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
206 INTENTIONAL DRUG MISUSE 24 0.0011
207 CARPAL TUNNEL SYNDROME 16 0.0011
208 DRUG ABUSE 95 0.0011
209 LOGORRHOEA 4 0.0011
210 LIGAMENT RUPTURE 5 0.0011
211 THINKING ABNORMAL 21 0.0011
212 FACIAL PAIN 10 0.0011
213 INTENTIONAL PRODUCT MISUSE 98 0.0011
214 GINGIVITIS 6 0.0011
215 INFUSION SITE SWELLING 7 0.0011
216 RESTLESS LEGS SYNDROME 20 0.0011
217 FOOD INTOLERANCE 4 0.0011
218 BRAIN NEOPLASM 10 0.0011
219 NERVE COMPRESSION 10 0.0011
220 DEEP VEIN THROMBOSIS 70 0.0011
221 ANGIOPATHY 6 0.0011
222 THERAPEUTIC RESPONSE UNEXPECTED 48 0.0011
223 DYSGRAPHIA 7 0.0011
224 DISTURBANCE IN ATTENTION 57 0.0011
225 TENDERNESS 11 0.0011
226 VITAMIN D DECREASED 9 0.0011
227 EAR INFECTION 28 0.0011
228 TROPONIN INCREASED 8 0.0011
229 SINUSITIS 106 0.0010
230 IMPAIRED GASTRIC EMPTYING 14 0.0010
231 SPINAL OSTEOARTHRITIS 9 0.0010
232 INJURY 72 0.0010
233 HEAD DISCOMFORT 18 0.0010
234 PHARYNGITIS STREPTOCOCCAL 11 0.0010
235 DIABETIC NEUROPATHY 5 0.0010
236 HYPERLIPIDAEMIA 12 0.0010
237 INJECTION SITE INFLAMMATION 5 0.0010
238 FOOT FRACTURE 19 0.0010
239 TOXIC SKIN ERUPTION 10 0.0010
240 BLINDNESS UNILATERAL 14 0.0010
241 SPEECH DISORDER 52 0.0010
242 ENURESIS 4 0.0010
243 APPLICATION SITE DISCOLOURATION 4 0.0010
244 PETIT MAL EPILEPSY 5 0.0010
245 INITIAL INSOMNIA 10 0.0010
246 SELF-MEDICATION 4 0.0010
247 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 6 0.0010
248 AORTIC DISSECTION 4 0.0010
249 NEPHROLITHIASIS 44 0.0010
250 CONTRAINDICATED PRODUCT ADMINISTERED 29 0.0010
251 TINNITUS 44 0.0010
252 PAIN IN JAW 27 0.0010
253 POLYARTHRITIS 5 0.0009
254 PHARYNGOLARYNGEAL PAIN 5 0.0009
255 INTERVERTEBRAL DISC DISORDER 4 0.0009
256 PRODUCT DISPENSING ISSUE 4 0.0009
257 SENSORY DISTURBANCE 15 0.0009
258 BRUXISM 5 0.0009
259 BLOOD IRON DECREASED 11 0.0009
260 PSYCHOLOGICAL TRAUMA 8 0.0009
261 CONVULSION 53 0.0009
262 MUSCLE STRAIN 8 0.0009
263 SOMNAMBULISM 6 0.0009
264 EMOTIONAL DISORDER 28 0.0009
265 INTESTINAL ISCHAEMIA 5 0.0009
266 FOOD ALLERGY 7 0.0009
267 ANKLE FRACTURE 14 0.0009
268 BREAST MASS 6 0.0009
269 FEELING ABNORMAL 214 0.0009
270 BRONCHITIS 66 0.0009
271 PREMATURE LABOUR 5 0.0009
272 CHOLECYSTITIS ACUTE 5 0.0009
273 DERMATITIS ALLERGIC 11 0.0009
274 PRODUCT DISPENSING ERROR 19 0.0009
275 ABDOMINAL PAIN LOWER 22 0.0009
276 FRUSTRATION TOLERANCE DECREASED 7 0.0009
277 SOMNOLENCE 174 0.0009
278 NEURALGIA 21 0.0009
279 WEIGHT FLUCTUATION 9 0.0009
280 APPENDICITIS 8 0.0009
281 CHOLELITHIASIS 28 0.0009
282 ENERGY INCREASED 5 0.0008
283 POISONING DELIBERATE 8 0.0008
284 JOINT INJURY 18 0.0008
285 NERVOUSNESS 44 0.0008
286 SARCOIDOSIS 4 0.0008
287 CHOLECYSTITIS 10 0.0008
288 BEDRIDDEN 11 0.0008
289 IMMUNE SYSTEM DISORDER 11 0.0008
290 LIMB OPERATION 4 0.0008
291 INFUSION SITE ERYTHEMA 7 0.0008
292 BACK INJURY 9 0.0008
293 DYSARTHRIA 31 0.0008
294 MAJOR DEPRESSION 6 0.0008
295 FEAR 22 0.0008
296 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 58 0.0008
297 AMNESIA 53 0.0008
298 CEREBRAL DISORDER 6 0.0008
299 CARDIAC MURMUR 7 0.0008
300 SCOLIOSIS 5 0.0008
301 MULTIPLE DRUG OVERDOSE 4 0.0008
302 SMALL FOR DATES BABY 4 0.0008
303 PROTEIN URINE PRESENT 4 0.0008
304 SURGERY 47 0.0008
305 OVARIAN CYST 8 0.0008
306 BREAST TENDERNESS 6 0.0008
307 ECONOMIC PROBLEM 12 0.0008
308 PHOTOPSIA 5 0.0008
309 OSTEOPENIA 12 0.0008
310 POOR QUALITY SLEEP 17 0.0008
311 DERMATITIS CONTACT 9 0.0008
312 COORDINATION ABNORMAL 11 0.0008
313 DYSLIPIDAEMIA 4 0.0008
314 GASTRIC DISORDER 27 0.0008
315 SCREAMING 5 0.0008
316 ANXIETY 223 0.0008
317 BLOOD TEST ABNORMAL 11 0.0008
318 DISSOCIATION 6 0.0008
319 DISORIENTATION 31 0.0008
320 DRUG PRESCRIBING ERROR 15 0.0008
321 PERIPHERAL VASCULAR DISORDER 4 0.0008
322 TEMPERATURE INTOLERANCE 8 0.0008
323 DYSTONIA 15 0.0008
324 HIATUS HERNIA 10 0.0008
325 MEMORY IMPAIRMENT 106 0.0008
326 PANIC ATTACK 28 0.0008
327 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
328 SUICIDAL IDEATION 70 0.0008
329 INSOMNIA 202 0.0008
330 NASAL DISCOMFORT 6 0.0008
331 MUSCULOSKELETAL DISCOMFORT 13 0.0008
332 CYSTITIS 24 0.0008
333 ACCIDENT 9 0.0008
334 PERSONALITY CHANGE 7 0.0008
335 COGNITIVE DISORDER 35 0.0007
336 MENINGITIS 5 0.0007
337 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41 0.0007
338 IRRITABLE BOWEL SYNDROME 16 0.0007
339 LOCAL SWELLING 13 0.0007
340 OVERWEIGHT 4 0.0007
341 PRODUCT PHYSICAL ISSUE 15 0.0007
342 CRYING 27 0.0007
343 DECREASED ACTIVITY 8 0.0007
344 POSTOPERATIVE WOUND INFECTION 5 0.0007
345 DRUG EXPOSURE DURING PREGNANCY 25 0.0007
346 FEELING HOT 45 0.0007
347 AFFECT LABILITY 7 0.0007
348 PHARYNGITIS 9 0.0007
349 CHOKING SENSATION 4 0.0007
350 LYMPHOEDEMA 5 0.0007
351 HAIR GROWTH ABNORMAL 5 0.0007
352 GASTROENTERITIS VIRAL 13 0.0007
353 TOOTH DISORDER 16 0.0007
354 CHEST PAIN 133 0.0007
355 INTRACRANIAL PRESSURE INCREASED 4 0.0007
356 WITHDRAWAL SYNDROME 30 0.0007
357 COMA 34 0.0007
358 DRUG USE DISORDER 6 0.0007
359 SENSATION OF FOREIGN BODY 6 0.0007
360 HEMIPARESIS 12 0.0007
361 HYPOAESTHESIA 106 0.0007
362 LIGAMENT SPRAIN 7 0.0007
363 OSTEOARTHRITIS 30 0.0007
364 VERTIGO 43 0.0007
365 NERVOUS SYSTEM DISORDER 22 0.0007
366 FACIAL PARALYSIS 6 0.0007
367 MYDRIASIS 9 0.0007
368 CHOLECYSTECTOMY 8 0.0007
369 VOMITING 329 0.0007
370 PARALYSIS 10 0.0007
371 INFUSION SITE PAIN 9 0.0007
372 PARAESTHESIA ORAL 10 0.0007
373 DRUG INEFFECTIVE 913 0.0007
374 VISUAL FIELD DEFECT 5 0.0007
375 PAIN 425 0.0007
376 SOCIAL AVOIDANT BEHAVIOUR 4 0.0007
377 TOOTH ABSCESS 7 0.0007
378 UTERINE LEIOMYOMA 5 0.0007
379 PULMONARY EMBOLISM 65 0.0007
380 TOOTH INFECTION 9 0.0007
381 FEELING JITTERY 13 0.0007
382 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
383 COLD SWEAT 12 0.0007
384 URINE ODOUR ABNORMAL 4 0.0007
385 LYMPHADENOPATHY 24 0.0007
386 PSYCHIATRIC SYMPTOM 5 0.0007
387 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
388 PALPITATIONS 79 0.0007
389 HAIR TEXTURE ABNORMAL 9 0.0007
390 QUALITY OF LIFE DECREASED 9 0.0007
391 ODYNOPHAGIA 4 0.0007
392 MYOSITIS 6 0.0007
393 MALAISE 292 0.0007
394 OROPHARYNGEAL DISCOMFORT 6 0.0007
395 HYPERSOMNIA 19 0.0007
396 LIMB INJURY 18 0.0007
397 KIDNEY INFECTION 13 0.0007
398 APHASIA 20 0.0007
399 RENAL PAIN 7 0.0007
400 MOOD ALTERED 18 0.0007
401 PERIPHERAL COLDNESS 9 0.0007
402 DEPRESSION 148 0.0006
403 UPPER RESPIRATORY TRACT INFECTION 30 0.0006
404 CONDITION AGGRAVATED 197 0.0006
405 ORAL DISCOMFORT 9 0.0006
406 LOW DENSITY LIPOPROTEIN INCREASED 5 0.0006
407 BLOOD CHOLESTEROL INCREASED 30 0.0006
408 INFUSION SITE EXTRAVASATION 4 0.0006
409 SWOLLEN TONGUE 20 0.0006
410 EYE DISORDER 21 0.0006
411 LACERATION 6 0.0006
412 TORSADE DE POINTES 5 0.0006
413 GASTROINTESTINAL PAIN 7 0.0006
414 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
415 ARTHRITIS 50 0.0006
416 TOOTH FRACTURE 7 0.0006
417 NAUSEA 502 0.0006
418 DENTAL CARIES 7 0.0006
419 RIB FRACTURE 13 0.0006
420 MUSCLE ATROPHY 8 0.0006
421 GASTRIC ULCER 12 0.0006
422 ASTHMA 71 0.0006
423 WHITE BLOOD CELL COUNT INCREASED 24 0.0006
424 ENTERITIS 4 0.0006
425 SKIN INFECTION 7 0.0006
426 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
427 ROTATOR CUFF SYNDROME 8 0.0006
428 SENSORY LOSS 5 0.0006
429 PRESCRIBED OVERDOSE 12 0.0006
430 EYE INFECTION 7 0.0006
431 REBOUND EFFECT 7 0.0006
432 CARDIAC FLUTTER 4 0.0006
433 HALLUCINATION, VISUAL 13 0.0006
434 PHARYNGEAL SWELLING 6 0.0006
435 DEAFNESS 16 0.0006
436 HYPERAESTHESIA 5 0.0006
437 BLOOD PRESSURE INCREASED 93 0.0006
438 TOOTHACHE 11 0.0006
439 INFLUENZA LIKE ILLNESS 50 0.0006
440 HAIR DISORDER 5 0.0006
441 MULTIPLE SCLEROSIS 29 0.0006
442 PELVIC PAIN 11 0.0006
443 DEPRESSED MOOD 32 0.0006
444 MENSTRUAL DISORDER 5 0.0006
445 ACUTE CORONARY SYNDROME 5 0.0006
446 HEAD INJURY 19 0.0006
447 MUSCULOSKELETAL STIFFNESS 52 0.0006
448 HYPOTHERMIA 6 0.0006
449 MUSCULOSKELETAL PAIN 31 0.0006
450 HEPATIC STEATOSIS 11 0.0006
451 EYELID PTOSIS 6 0.0006
452 BALANCE DISORDER 51 0.0006
453 EUPHORIC MOOD 6 0.0006
454 LIVER FUNCTION TEST ABNORMAL 17 0.0006
455 EYE MOVEMENT DISORDER 4 0.0006
456 WRIST FRACTURE 7 0.0006
457 MENTAL IMPAIRMENT 14 0.0006
458 HYSTERECTOMY 5 0.0006
459 HUNGER 8 0.0006
460 LOWER LIMB FRACTURE 11 0.0006
461 DEFAECATION URGENCY 4 0.0006
462 ANHEDONIA 15 0.0006
463 GASTROINTESTINAL DISORDER 51 0.0006
464 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
465 SPINAL OPERATION 7 0.0006
466 PAPULE 4 0.0006
467 JOINT DISLOCATION 6 0.0006
468 TENDON RUPTURE 7 0.0006
469 SLEEP DISORDER 40 0.0006
470 HEPATOCELLULAR INJURY 8 0.0006
471 EATING DISORDER 12 0.0006
472 DIVERTICULUM 4 0.0006
473 HAIR COLOUR CHANGES 7 0.0006
474 CONTUSION 54 0.0006
475 TREMOR 93 0.0006
476 HYPERSENSITIVITY 104 0.0006
477 MENORRHAGIA 11 0.0006
478 ABDOMINAL PAIN UPPER 115 0.0006
479 CARDIOGENIC SHOCK 8 0.0006
480 DISABILITY 11 0.0006
481 MUSCLE SPASMS 102 0.0006
482 DRUG ADMINISTRATION ERROR 17 0.0006
483 DYSSTASIA 16 0.0005
484 EXOSTOSIS 5 0.0005
485 GASTROOESOPHAGEAL REFLUX DISEASE 44 0.0005
486 LOSS OF CONSCIOUSNESS 70 0.0005
487 PRODUCT PRESCRIBING ERROR 13 0.0005
488 INCREASED TENDENCY TO BRUISE 5 0.0005
489 GRAND MAL CONVULSION 5 0.0005
490 DIZZINESS 270 0.0005
491 ARTHROPOD BITE 4 0.0005
492 PRODUCT DISTRIBUTION ISSUE 5 0.0005
493 VISION BLURRED 74 0.0005
494 ABDOMINAL DISCOMFORT 90 0.0005
495 DEFORMITY 5 0.0005
496 THROAT IRRITATION 24 0.0005
497 INTESTINAL PERFORATION 6 0.0005
498 BLOOD POTASSIUM DECREASED 16 0.0005
499 HYPOAESTHESIA ORAL 8 0.0005
500 INJECTION SITE URTICARIA 13 0.0005
501 TACHYCARDIA 47 0.0005
502 DRUG DEPENDENCE 85 0.0005
503 DYSPEPSIA 52 0.0005
504 DYSMENORRHOEA 7 0.0005
505 SCAR 9 0.0005
506 MULTIPLE SCLEROSIS RELAPSE 36 0.0005
507 ACIDOSIS 4 0.0005
508 INSURANCE ISSUE 8 0.0005
509 BOWEL MOVEMENT IRREGULARITY 4 0.0005
510 PRODUCT SUBSTITUTION ISSUE 30 0.0005
511 CHOLESTASIS 10 0.0005
512 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 25 0.0005
513 THYROID DISORDER 8 0.0005
514 SINUS CONGESTION 7 0.0005
515 DRUG INTOLERANCE 50 0.0005
516 HERNIA 10 0.0005
517 LIMB DISCOMFORT 16 0.0005
518 MADAROSIS 6 0.0005
519 CONGENITAL ANOMALY 4 0.0005
520 HYPERTENSION 109 0.0005
521 EAR PAIN 10 0.0005
522 BURNING SENSATION 36 0.0005
523 VITAMIN D DEFICIENCY 5 0.0005
524 HYPERHIDROSIS 66 0.0005
525 VISUAL ACUITY REDUCED 17 0.0005
526 HYPOACUSIS 22 0.0005
527 PANCREATITIS 27 0.0005
528 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
529 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
530 VITREOUS FLOATERS 5 0.0005
531 BACK PAIN 118 0.0005
532 DRUG ERUPTION 9 0.0005
533 SWELLING FACE 33 0.0005
534 DRUG SCREEN POSITIVE 4 0.0005
535 EMBEDDED DEVICE 5 0.0005
536 ANGER 17 0.0005
537 GINGIVAL PAIN 4 0.0005
538 MACULAR DEGENERATION 6 0.0005
539 OBESITY 8 0.0005
540 FLUSHING 51 0.0005
541 PRESCRIBED UNDERDOSE 10 0.0005
542 DIPLOPIA 13 0.0005
543 ABORTION SPONTANEOUS 20 0.0005
544 RESPIRATORY TRACT INFECTION 13 0.0005
545 NASOPHARYNGITIS 92 0.0005
546 MOVEMENT DISORDER 16 0.0005
547 SEDATION 13 0.0005
548 WEIGHT INCREASED 111 0.0005
549 BURSITIS 6 0.0005
550 NOCTURIA 6 0.0005
551 MUSCLE DISORDER 4 0.0005
552 FEEDING DISORDER 10 0.0005
553 INJECTION SITE PRURITUS 33 0.0005
554 MUSCLE SPASTICITY 6 0.0005
555 MYALGIA 83 0.0005
556 CHRONIC KIDNEY DISEASE 37 0.0005
557 INJECTION SITE WARMTH 10 0.0005
558 ARTHROPATHY 27 0.0005
559 DIABETES MELLITUS 37 0.0005
560 DRUG INTERACTION 77 0.0005
561 STAPHYLOCOCCAL INFECTION 16 0.0005
562 URTICARIA 81 0.0005
563 POOR VENOUS ACCESS 5 0.0005
564 MIDDLE INSOMNIA 9 0.0005
565 HEMIPLEGIA 4 0.0005
566 POLLAKIURIA 20 0.0005
567 PETECHIAE 5 0.0005
568 EYE PAIN 27 0.0005
569 LIVE BIRTH 4 0.0005
570 TYPE 2 DIABETES MELLITUS 16 0.0005
571 INCONTINENCE 5 0.0005
572 INJECTION SITE IRRITATION 6 0.0005
573 ABNORMAL DREAMS 13 0.0005
574 MOOD SWINGS 15 0.0005
575 CONFUSIONAL STATE 76 0.0005
576 EXPOSURE DURING PREGNANCY 29 0.0005
577 PSEUDOMONAS INFECTION 4 0.0005
578 BLINDNESS 19 0.0005
579 ILLNESS 48 0.0005
580 PARANOIA 8 0.0005
581 DYSPHAGIA 44 0.0005
582 INJECTION SITE INDURATION 6 0.0005
583 SYNCOPE 46 0.0005
584 MENTAL DISORDER 20 0.0005
585 INTENTIONAL PRODUCT USE ISSUE 40 0.0005
586 INJECTION SITE RASH 14 0.0005
587 DRY MOUTH 37 0.0005
588 INTENTIONAL DOSE OMISSION 13 0.0005
589 ORAL CANDIDIASIS 6 0.0005
590 ABNORMAL BEHAVIOUR 18 0.0005
591 ANGINA PECTORIS 13 0.0005
592 LYMPHOCYTE COUNT DECREASED 8 0.0005
593 TENDONITIS 7 0.0005
594 FOOT DEFORMITY 5 0.0005
595 FALL 150 0.0005
596 PREGNANCY 9 0.0004
597 MUSCULAR WEAKNESS 51 0.0004
598 HEART RATE INCREASED 44 0.0004
599 OSTEOMYELITIS 8 0.0004
600 MITRAL VALVE INCOMPETENCE 5 0.0004
601 LUPUS-LIKE SYNDROME 4 0.0004
602 PALLOR 12 0.0004
603 INFLUENZA 49 0.0004
604 BONE DISORDER 8 0.0004
605 HYPOTHYROIDISM 14 0.0004
606 EMOTIONAL DISTRESS 53 0.0004
607 MICTURITION URGENCY 5 0.0004
608 CORONARY ARTERY OCCLUSION 6 0.0004
609 UNEVALUABLE EVENT 33 0.0004
610 AGITATION 32 0.0004
611 RETINAL DETACHMENT 4 0.0004
612 NIGHT SWEATS 14 0.0004
613 PAIN IN EXTREMITY 128 0.0004
614 NIGHTMARE 15 0.0004
615 PROCEDURAL PAIN 12 0.0004
616 IRRITABILITY 26 0.0004
617 PREMATURE BABY 13 0.0004
618 FEELING COLD 12 0.0004
619 FATIGUE 335 0.0004
620 APHONIA 6 0.0004
621 LUNG DISORDER 21 0.0004
622 DYSPHONIA 25 0.0004
623 INJECTION SITE PAIN 131 0.0004
624 DRUG EFFECT DECREASED 23 0.0004
625 FLANK PAIN 4 0.0004
626 NASAL CONGESTION 25 0.0004
627 EPILEPSY 13 0.0004
628 RASH GENERALISED 11 0.0004
629 SEIZURE 49 0.0004
630 THERAPEUTIC PRODUCT EFFECT DECREASED 19 0.0004
631 PRODUCT USE IN UNAPPROVED INDICATION 105 0.0004
632 GENERALISED TONIC-CLONIC SEIZURE 7 0.0004
633 TREATMENT FAILURE 35 0.0004
634 CONSTIPATION 92 0.0004
635 VISUAL IMPAIRMENT 52 0.0004
636 MYOCLONUS 5 0.0004
637 GLAUCOMA 8 0.0004
638 ATELECTASIS 4 0.0004
639 INJECTION SITE HAEMATOMA 6 0.0004
640 OSTEOPOROSIS 17 0.0004
641 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
642 PRESYNCOPE 10 0.0004
643 CEREBRAL INFARCTION 10 0.0004
644 ABDOMINAL PAIN 95 0.0004
645 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
646 CARDIOMEGALY 5 0.0004
647 CARDIOMYOPATHY 6 0.0004
648 URINARY INCONTINENCE 12 0.0004
649 ABASIA 10 0.0004
650 CYST 5 0.0004
651 BLOOD PRESSURE ABNORMAL 8 0.0004
652 HYPOTONIA 4 0.0004
653 DRY EYE 20 0.0004
654 INJECTION SITE DISCOLOURATION 5 0.0004
655 OROPHARYNGEAL PAIN 37 0.0004
656 URINARY TRACT INFECTION 68 0.0004
657 HEART RATE IRREGULAR 9 0.0004
658 INTESTINAL OBSTRUCTION 15 0.0004
659 LACRIMATION INCREASED 12 0.0004
660 GAIT DISTURBANCE 76 0.0004
661 PERITONITIS BACTERIAL 4 0.0004
662 INJECTION SITE ERYTHEMA 49 0.0004
663 DRY THROAT 4 0.0004
664 DISCOMFORT 24 0.0004
665 THERAPEUTIC RESPONSE SHORTENED 13 0.0004
666 EXPIRED PRODUCT ADMINISTERED 13 0.0004
667 HEPATITIS 10 0.0004
668 LIP SWELLING 13 0.0004
669 DYSGEUSIA 29 0.0004
670 FUNGAL INFECTION 13 0.0004
671 TARDIVE DYSKINESIA 11 0.0004
672 EAR DISCOMFORT 4 0.0004
673 DELUSION 6 0.0004
674 VENTRICULAR EXTRASYSTOLES 4 0.0004
675 EYE DISCHARGE 4 0.0004
676 WEIGHT DECREASED 107 0.0004
677 NODULE 5 0.0004
678 BRAIN FOG 6 0.0004
679 LETHARGY 22 0.0004
680 PRODUCT ODOUR ABNORMAL 4 0.0004
681 ANKYLOSING SPONDYLITIS 5 0.0004
682 ULCER 6 0.0004
683 BREAST CANCER FEMALE 10 0.0004
684 MALIGNANT MELANOMA 5 0.0004
685 THROMBOSIS 30 0.0004
686 CEREBROVASCULAR ACCIDENT 63 0.0004
687 FREQUENT BOWEL MOVEMENTS 10 0.0004
688 PRURITUS GENERALISED 8 0.0004
689 CATARACT 22 0.0004
690 COLITIS 14 0.0004
691 ALTERED STATE OF CONSCIOUSNESS 8 0.0004
692 PRODUCT TASTE ABNORMAL 5 0.0004
693 DYSKINESIA 15 0.0004
694 MUSCULOSKELETAL DISORDER 7 0.0004
695 DEHYDRATION 49 0.0004
696 PULMONARY THROMBOSIS 4 0.0004
697 OESOPHAGITIS 4 0.0004
698 DYSPNOEA 207 0.0004
699 MANIA 6 0.0004
700 APPLICATION SITE RASH 5 0.0004
701 THERAPEUTIC RESPONSE DECREASED 22 0.0004
702 ANAPHYLACTIC REACTION 20 0.0004
703 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
704 VIRAL INFECTION 12 0.0004
705 URINARY RETENTION 12 0.0004
706 INFECTION 52 0.0004
707 COVID-19 63 0.0004
708 ORAL HERPES 7 0.0004
709 MASS 5 0.0004
710 ALOPECIA 70 0.0004
711 OCULAR DISCOMFORT 4 0.0004
712 FISTULA 4 0.0004
713 FACE OEDEMA 6 0.0004
714 STATUS EPILEPTICUS 4 0.0004
715 ASTHENIA 133 0.0004
716 INJECTION SITE SWELLING 27 0.0004
717 CIRCULATORY COLLAPSE 6 0.0004
718 PRODUCT AVAILABILITY ISSUE 8 0.0004
719 EYE SWELLING 13 0.0003
720 NEOPLASM 4 0.0003
721 MOBILITY DECREASED 25 0.0003
722 MUSCLE TWITCHING 8 0.0003
723 SUICIDE ATTEMPT 21 0.0003
724 HYPERTHYROIDISM 5 0.0003
725 HYPOKINESIA 5 0.0003
726 EYELID OEDEMA 4 0.0003
727 ARTHRALGIA 143 0.0003
728 INJURY ASSOCIATED WITH DEVICE 7 0.0003
729 APPLICATION SITE ERYTHEMA 9 0.0003
730 VASCULITIS 4 0.0003
731 BODY TEMPERATURE INCREASED 7 0.0003
732 JOINT STIFFNESS 9 0.0003
733 GASTROENTERITIS 5 0.0003
734 GASTRITIS 9 0.0003
735 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
736 INJECTION SITE HAEMORRHAGE 27 0.0003
737 ARRHYTHMIA 16 0.0003
738 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
739 ATAXIA 4 0.0003
740 ISCHAEMIC STROKE 6 0.0003
741 SYNOVITIS 6 0.0003
742 KNEE ARTHROPLASTY 7 0.0003
743 BLOOD PRESSURE DECREASED 22 0.0003
744 DRUG WITHDRAWAL SYNDROME 29 0.0003
745 GAIT INABILITY 11 0.0003
746 UNDERDOSE 24 0.0003
747 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
748 INTENTIONAL OVERDOSE 21 0.0003
749 HIP ARTHROPLASTY 5 0.0003
750 RESPIRATORY DEPRESSION 4 0.0003
751 LYMPHOMA 5 0.0003
752 CONJUNCTIVITIS 6 0.0003
753 MUSCULOSKELETAL CHEST PAIN 5 0.0003
754 EPISTAXIS 24 0.0003
755 AGEUSIA 8 0.0003
756 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
757 HOT FLUSH 24 0.0003
758 APPLICATION SITE PAIN 7 0.0003
759 BLOOD URINE PRESENT 6 0.0003
760 NEUROPATHY PERIPHERAL 30 0.0003
761 DRUG DOSE OMISSION 52 0.0003
762 MATERNAL EXPOSURE DURING PREGNANCY 28 0.0003
763 PREMATURE DELIVERY 5 0.0003
764 INJECTION SITE BRUISING 25 0.0003
765 ILL-DEFINED DISORDER 19 0.0003
766 GLOSSODYNIA 7 0.0003
767 POST PROCEDURAL COMPLICATION 6 0.0003
768 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
769 NEEDLE ISSUE 9 0.0003
770 PHARMACEUTICAL PRODUCT COMPLAINT 8 0.0003
771 PLATELET COUNT INCREASED 4 0.0003
772 INCORRECT DOSE ADMINISTERED BY DEVICE 8 0.0003
773 IMPAIRED HEALING 10 0.0003
774 SOPOR 4 0.0003
775 UPPER LIMB FRACTURE 6 0.0003
776 SPINAL FRACTURE 6 0.0003
777 CARDIAC DISORDER 28 0.0003
778 DYSURIA 11 0.0003
779 PAIN OF SKIN 8 0.0003
780 INTENTIONAL SELF-INJURY 6 0.0003
781 HERPES ZOSTER 17 0.0003
782 PSORIATIC ARTHROPATHY 12 0.0003
783 OCULAR HYPERAEMIA 14 0.0003
784 ANGIOEDEMA 13 0.0003
785 HEPATIC ENZYME INCREASED 20 0.0003
786 DYSPNOEA EXERTIONAL 11 0.0003
787 RESPIRATORY DISTRESS 8 0.0003
788 ADVERSE DRUG REACTION 26 0.0003
789 LOCALISED INFECTION 7 0.0003
790 MENTAL STATUS CHANGES 8 0.0003
791 ABDOMINAL DISTENSION 30 0.0003
792 ORTHOSTATIC HYPOTENSION 5 0.0003
793 HAEMOPTYSIS 8 0.0003
794 ENCEPHALOPATHY 7 0.0003
795 PRODUCT USE ISSUE 53 0.0003
796 EXTRAPYRAMIDAL DISORDER 7 0.0003
797 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
798 SINUS TACHYCARDIA 4 0.0003
799 CHILLS 33 0.0003
800 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 20 0.0003
801 PRURITUS 108 0.0003
802 MYOCARDIAL INFARCTION 49 0.0003
803 BRONCHOSPASM 4 0.0003
804 HIP FRACTURE 9 0.0003
805 RHINORRHOEA 18 0.0003
806 IMPAIRED QUALITY OF LIFE 4 0.0003
807 ANOSMIA 4 0.0003
808 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
809 APATHY 4 0.0003
810 END STAGE RENAL DISEASE 5 0.0003
811 DISEASE RECURRENCE 13 0.0003
812 BONE PAIN 16 0.0003
813 PRODUCT QUALITY ISSUE 37 0.0003
814 HAEMATOCHEZIA 15 0.0003
815 PSYCHOTIC DISORDER 8 0.0003
816 PULMONARY MASS 4 0.0003
817 DIARRHOEA 172 0.0003
818 FLATULENCE 15 0.0003
819 OFF LABEL USE 231 0.0003
820 RHABDOMYOLYSIS 11 0.0003
821 ERYTHEMA 54 0.0003
822 INCREASED APPETITE 5 0.0003
823 MENSTRUATION IRREGULAR 7 0.0003
824 PRODUCT DOSE OMISSION 17 0.0003
825 DEVICE RELATED INFECTION 4 0.0003
826 COUGH 72 0.0003
827 BASAL CELL CARCINOMA 4 0.0003
828 HAEMORRHOIDS 5 0.0003
829 CHOKING 5 0.0003
830 RENAL FAILURE 34 0.0003
831 RECTAL HAEMORRHAGE 11 0.0003
832 OVERDOSE 55 0.0003
833 CYANOSIS 4 0.0003
834 HALLUCINATION 19 0.0003
835 ABSCESS 4 0.0003
836 WOUND 7 0.0003
837 BLOOD PRESSURE FLUCTUATION 6 0.0002
838 PYREXIA 86 0.0002
839 FULL BLOOD COUNT DECREASED 5 0.0002
840 INJECTION SITE REACTION 17 0.0002
841 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 50 0.0002
842 COLITIS ULCERATIVE 11 0.0002
843 SWELLING 23 0.0002
844 MULTIPLE FRACTURES 4 0.0002
845 PRODUCT PREPARATION ERROR 5 0.0002
846 PRODUCT DOSE OMISSION ISSUE 71 0.0002
847 INFUSION RELATED REACTION 16 0.0002
848 TOOTH LOSS 5 0.0002
849 SKIN DISORDER 8 0.0002
850 AGGRESSION 12 0.0002
851 NEOPLASM MALIGNANT 16 0.0002
852 HYPOTENSION 48 0.0002
853 HYPOKALAEMIA 11 0.0002
854 CELLULITIS 12 0.0002
855 EYE PRURITUS 8 0.0002
856 DECREASED APPETITE 55 0.0002
857 FLUID RETENTION 12 0.0002
858 RENAL INJURY 7 0.0002
859 PNEUMONIA 76 0.0002
860 RESPIRATORY DISORDER 7 0.0002
861 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
862 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 42 0.0002
863 ANAPHYLACTIC SHOCK 6 0.0002
864 DELIRIUM 8 0.0002
865 VAGINAL HAEMORRHAGE 10 0.0002
866 RHEUMATOID ARTHRITIS 26 0.0002
867 MELAENA 5 0.0002
868 BRADYCARDIA 12 0.0002
869 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
870 LIVER DISORDER 10 0.0002
871 THERAPY INTERRUPTED 16 0.0002
872 CEREBRAL HAEMORRHAGE 8 0.0002
873 RASH PAPULAR 5 0.0002
874 JAUNDICE 6 0.0002
875 SNEEZING 5 0.0002
876 FOETAL EXPOSURE DURING PREGNANCY 18 0.0002
877 RASH PRURITIC 12 0.0002
878 COMPLICATION OF DEVICE REMOVAL 4 0.0002
879 TREATMENT NONCOMPLIANCE 12 0.0002
880 WHEEZING 13 0.0002
881 SKIN LESION 6 0.0002
882 INJECTION SITE MASS 8 0.0002
883 MEDICATION ERROR 12 0.0002
884 RENAL DISORDER 10 0.0002
885 OSTEONECROSIS 7 0.0002
886 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
887 FRACTURE 4 0.0002
888 PROTEINURIA 4 0.0002
889 NO ADVERSE EVENT 38 0.0002
890 RASH ERYTHEMATOUS 10 0.0002
891 BLOOD GLUCOSE DECREASED 10 0.0002
892 JOINT SWELLING 25 0.0002
893 RASH 90 0.0002
894 HAEMATURIA 7 0.0002
895 RASH MACULAR 7 0.0002
896 HEART RATE DECREASED 7 0.0002
897 GENERAL PHYSICAL HEALTH DETERIORATION 23 0.0002
898 PRODUCT ADMINISTRATION ERROR 4 0.0002
899 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
900 HAEMATEMESIS 5 0.0002
901 THERAPY CESSATION 10 0.0002
902 PERIPHERAL SWELLING 30 0.0002
903 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
904 CARDIAC ARREST 16 0.0002
905 BREAST CANCER 18 0.0002
906 INCORRECT DOSE ADMINISTERED 44 0.0002
907 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
908 RESTLESSNESS 7 0.0002
909 MOUTH ULCERATION 4 0.0002
910 LIVER FUNCTION TEST INCREASED 4 0.0002
911 SKIN CANCER 4 0.0002
912 OEDEMA 10 0.0002
913 DEVICE DIFFICULT TO USE 12 0.0002
914 OEDEMA PERIPHERAL 22 0.0002
915 DIVERTICULITIS 5 0.0002
916 RASH MACULO-PAPULAR 4 0.0002
917 BLISTER 10 0.0002
918 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
919 APPLICATION SITE PRURITUS 4 0.0002
920 ATRIAL FIBRILLATION 17 0.0002
921 INFLAMMATION 9 0.0002
922 SKIN DISCOLOURATION 8 0.0002
923 ADVERSE EVENT 16 0.0002
924 EXTRA DOSE ADMINISTERED 7 0.0002
925 DEVICE MALFUNCTION 12 0.0002
926 SEPSIS 19 0.0002
927 LABORATORY TEST ABNORMAL 5 0.0002
928 PRODUCT ADHESION ISSUE 6 0.0002
929 DEVICE ISSUE 15 0.0002
930 WHITE BLOOD CELL COUNT DECREASED 18 0.0002
931 CORONARY ARTERY DISEASE 5 0.0002
932 ACCIDENTAL EXPOSURE TO PRODUCT 17 0.0002
933 STOMATITIS 10 0.0002
934 RESPIRATORY FAILURE 12 0.0002
935 ACUTE KIDNEY INJURY 25 0.0002
936 HAEMORRHAGE 17 0.0002
937 FEMUR FRACTURE 5 0.0002
938 PNEUMONIA ASPIRATION 4 0.0002
939 DRY SKIN 21 0.0002
940 METABOLIC ACIDOSIS 5 0.0002
941 UNRESPONSIVE TO STIMULI 4 0.0002
942 HAEMATOMA 4 0.0002
943 ANAEMIA 29 0.0002
944 HOSPITALISATION 23 0.0001
945 BLOOD BILIRUBIN INCREASED 4 0.0001
946 DEVICE BREAKAGE 6 0.0001
947 PRODUCTIVE COUGH 7 0.0001
948 RESPIRATORY ARREST 4 0.0001
949 SKIN EXFOLIATION 12 0.0001
950 INCORRECT DRUG ADMINISTRATION DURATION 4 0.0001
951 EYE IRRITATION 8 0.0001
952 DEVICE LEAKAGE 6 0.0001
953 SEPTIC SHOCK 6 0.0001
954 BLOOD CREATININE INCREASED 9 0.0001
955 C-REACTIVE PROTEIN INCREASED 5 0.0001
956 ACUTE MYOCARDIAL INFARCTION 4 0.0001
957 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
958 THERAPY NON-RESPONDER 6 0.0001
959 ACNE 10 0.0001
960 BONE DENSITY DECREASED 4 0.0001
961 DISEASE PROGRESSION 15 0.0001
962 SKIN BURNING SENSATION 9 0.0001
963 OXYGEN SATURATION DECREASED 7 0.0001
964 PSORIASIS 16 0.0001
965 LEUKOPENIA 6 0.0001
966 DRUG DOSE OMISSION BY DEVICE 9 0.0001
967 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
968 BLOOD GLUCOSE INCREASED 21 0.0001
969 ACCIDENTAL OVERDOSE 4 0.0001
970 HEPATIC FUNCTION ABNORMAL 4 0.0001
971 HAEMOGLOBIN DECREASED 11 0.0001
972 HYPOGLYCAEMIA 5 0.0001
973 CARDIAC FAILURE 8 0.0001
974 RENAL FAILURE ACUTE 4 0.0001
975 PLATELET COUNT DECREASED 10 0.0001
976 DEVICE DISLOCATION 4 0.0001
977 PRODUCT STORAGE ERROR 8 0.0001
978 DEPENDENCE 5 0.0001
979 SKIN IRRITATION 4 0.0001
980 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
981 RENAL IMPAIRMENT 7 0.0001
982 PLEURAL EFFUSION 5 0.0001
983 TOXICITY TO VARIOUS AGENTS 13 0.0001
984 FEBRILE NEUTROPENIA 5 0.0001
985 CARDIAC FAILURE CONGESTIVE 6 0.0001
986 NEUTROPENIA 9 0.0001
987 DEVICE EXPULSION 4 0.0001
988 COMPLETED SUICIDE 5 0.0001
989 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
990 THROMBOCYTOPENIA 5 0.0000
991 DEATH 33 0.0000